Issue of Equity/Total Voting Rights

Mycelx Technologies Corporation

3 January 2013

Mycelx Technologies Corporation

("Mycelx" or the "Company" (AIM: MYX)

Exercise of Share Options

The Company announces that on 31 December 2012, 13,657 options were exercised under the Company's Omnibus Performance Incentive Plan 2011 over common shares of US$0.025 each ("Common Shares") at a price of US$3.44 per Common Share.

Application has been made for the admission of 13,657 Common Shares to trading on AIM. The shares will rank pari passu with existing Common Shares and it is expected that admission will occur at 8.00 am on 8 January 2013.

Total Voting Rights

Following Admission of the 13,657 new Common Shares, the total number of voting rights in the Company's Common Shares will be 12,936,530 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Mycelx under the Financial Service Authority's Disclosure and Transparency Rules.

Enquiries

MyCelx Technologies Corporation +1 888 306 6843

Connie Mixon - CEO

Mark Clark - CFO

Numis Securities Limited +44 207 260 1000

Corporate Finance/Nominated Adviser

Alastair Stratton

Stuart Skinner

Corporate Broking

James Black

Ben Stoop